Singapore: Bayer HealthCare has stopped its phase II/III study testing its experimental treatment BAY 86-6150 on certain haemophilia A and B patients due to safety... Read more
Singapore: Fisher & Paykel Healthcare has introduced F&P ICON+, the next generation of its flow generator range for use in the treatment of obstructive sleep apnea... Read more
Singapore: Concert Pharmaceuticals entered into a strategic collaboration with Celgene Corporation directed towards deuterium-modified compounds targeting cancer... Read more
Singapore: Aeras, a nonprofit biotech firm that is advancing TB vaccines, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell... Read more
Singapore: The American College of Chest Physicians (ACCP) has recommended that people, who are being screened for lung cancer and already face a significant risk... Read more
Singapore: AbbVie's investigational direct-acting antiviral (DAA) combination with and without ribavirin for the treatment of genotype (GT1) hepatitis C virus (HCV)... Read more
Singapore: Cervarix has now been approved for use in females aged nine-to-25 years to prevent persistent infection, premalignant cervical lesions and cervical cancer... Read more
Singapore: Merck, also known as MSD outside the US and Canada, received US FDA approval for Liptruzet (ezetimibe and atorvastatin) tablets for the treatment of elevated... Read more
Singapore: US-based Regeneron Pharmaceuticals has acquired exclusive rights to two families of novel antibodies from Sanofi. Regeneron acquired full rights to antibodies... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
